Home>News Services>Associated Press

Associated Press

European Committee Says Alzheimer's Treatment Leqembi shouldn't Get Marketing Approval

AP24208465310572

Return to article

AP

13:37 JST, July 27, 2024

Shares of Biogen slid Friday after a European regulatory committee said the Alzheimer’s treatment Leqembi should not receive marketing approval.

Add TheJapanNews to your Google News feed.

New contents

JN ACCESS RANKING

Philippines Steps Up Defense of Northernmost Province with Eye on Possible Contingency Involving Taiwan
Typhoon Shanshan Forms, Slowly Moves Toward Japan; Govt Says Typhoon No. 10 Likely to Approach Japan Next Week
Tokyo Companies Prepare for Ashfall From Mt. Fuji Eruption; Disposal Of Ash, Possibly at Sea, A Major Challenge
Shizuoka Pref. City Offers Foreigners Free Japanese Language Classes; Aims to Raise Non-Natives to Daily Conversation Level
Typhoon No. 10 Forecast to Develop; Move into Pacific Ocean South of Japan on Aug. 26